OrthoPediatrics said yesterday it launched its pediatric-specific wrist fusion plate system as part of its PediFrag franchise. The wrist fusion plate system includes plates in two implant lengths to accomodate patients with and without proximal row carpectomies and features low-profile stainless steel plates to minimize plate prominence and reduce soft-tissue irritation, the Warsaw, Ind.-based company said. […]
OrthoPediatrics today priced its initial public offering at $13 per share, meaning the 4-million-share flotation pulled in $52 million for its line of surgical systems for children. The offering includes a 30-day underwriters over-allotment of 600,000 extra shares, which if fully exercised would push the IPO’s total raise to $59.8 million. Warsaw, Ind.-based OrthoPediatrics produces 21 surgical […]
OrthoPediatrics yesterday priced the range on its initial public offering, looking to float 4 million shares of common stock at between $12 and $14 per share, which would bring in between $48 and $56 million. The offering also includes a 30-day underwriter’s option to purchase an additional 600,000 shares of common stock, bringing the possible […]
OrthoPediatrics said this week it filed for an initial public offering, looking to bring in $57.5 million for the company and its pediatric-focused orthopedic device offering. The Warsaw, Ind.-based company said it plans to list on the NASDAQ exchange under the “KIDS” symbol, but has not determined what number of shares will be offered or […]
OrthoPediatrics, which says it is the only medical device company exclusively devoted to orthopedic implants for children, this week registered for an initial public offering worth $75 million. Based in the orthopedics hotbed of Warsaw, Ind., OrthoPediatrics plans to list on the NASDAQ exchange under the “KIDS” symbol. The company counts Squadron Capital among its […]
ETEX Corp. inked a non-exclusive deal with an Indiana company to distribute a bone putty used in spinal fusion treatments.
OrthoPediatrics Corp. will sell the Cambridge, Mass.-based company’s nanocrystalline calcium phosphate into the pediatric market in the U.S. and Canada. The product is used in spinal fusion procedures to fill bone voids or skeletal defects "that are not intrinsic to the stability of the bone structure," according to a press release.